Connect with us
NurExone Biologic Inc.’s nomination for the 2025 Prix Galien Bridges Award places it alongside Roche and Novo Nordisk, highlighting its rising global visibility. Its exosome-based regenerative...
AI Venture Builder raised £2.5M on Republic Europe, reaching over £4M total funding. The italo-UK company develops AI solutions for defense, cybersecurity, fashion, fintech, and healthcare....
HashKey Holdings won HKEX approval to proceed with an IPO that could raise up to $500 million. The company now enters marketing to gauge demand for...
The bond market is gradually normalizing as bank liquidity slightly improves and short-term issuance strengthens. Bullish signals appear across maturities, with investors favoring short-term flexibility. Yields...
Tether’s USDT, worth $186B, faces scrutiny after S&P downgraded its stability rating to “weak,” citing reserve concerns. CEO Paolo Ardoino rejects this, arguing critics ignore Tether’s...
Cotton prices rose last week and may be forming a daily chart low. Demand remains quiet despite positive but dated export sales. Farmers are holding back...
Farmaindustria’s Farma-Biotech program links researchers and start-ups with pharmaceutical companies to advance innovative medicines. At its 26th cooperation meeting, seven Spanish projects in oncology, obesity, nephrology,...
The Swiss Hemp Association welcomes Switzerland’s draft Cannabis Act as a historic shift toward regulated, science-based legalization but urges key improvements. It argues Switzerland can outperform...
The EU Health Council meets December 2 to advance key pharmaceutical and health files before the legislative transition. Discussions cover medicine supply security, regulatory reform, wastewater...
The Fed is split between hawks worried about inflation and doves fearing recession. Such divisions have historically preceded market downturns. With an 87% chance of a...